Skip to main content
OpenTrials

Clinical trial condition

Cytopenia

Explore clinical trials studying Cytopenia. Study availability and eligibility vary by location and protocol.

1,006 public trials 191 recruiting studies
Refine in advanced search Browse all conditions

Cytopenia trial results

Active, Not Recruiting

A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Participants With International Prognostic Scoring System Revised (IPSS-R) Low- or Intermediate-risk Myelodysplastic Syndrome (MDS)

NCT05469737

Conditions
Anemia, Blood Platelet Disorders, Bone Marrow Diseases, +5 more
Locations
  • Local Institution - 0137 Miami, Florida, United States
  • Local Institution - 0147 Tamarac, Florida, United States
  • Local Institution - 0132 East Syracuse, New York, United States
  • Local Institution - 0073 Pittsburgh, Pennsylvania, United States
View all 65 locations
View Trial Details
Active, Not Recruiting

Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)

NCT04562766

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • University of Southern California_Investigational Site Number 84024 Los Angeles, California, United States
  • UCSF Benioff Children's Hospital San Francisco_Investigational Site Number 84020 San Francisco, California, United States
  • Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center_Investigational Site Number 84037 Torrance, California, United States
  • The Oncology Institute of Hope and Innovation_Investigational Site Number 84031 Whittier, California, United States
View all 155 locations
View Trial Details
Active, Not Recruiting

Improvement of Immunologic and Molecular Techniques for the Diagnosis and Follow-up of Patients With Thrombotic Thrombocytopenic Purpura

NCT05046717

Conditions
Acquired Thrombotic Thrombocytopenic Purpura, Blood Coagulation Disorders, Blood Platelet Disorders, +14 more
Locations
  • Centro Hospitalar e Universitario de Coimbra Coimbra, Coimbra District, Portugal
  • Complejo Hospitalario Universitario A Coruña A Coruña, Spain
  • Hospital Clinic de Barcelona Barcelona, Spain
  • Hospital Clínico San Carlos Madrid, Spain
View Trial Details
Active, Not Recruiting

A Phase 3 Study to Evaluate the Safety and Efficacy of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia

NCT04812925

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Investigator Site 0010116 Bentonville, Arkansas, United States
  • Investigator site 0010045 Washington D.C., District of Columbia, United States
  • Investigator Site 0010062 Fort Wayne, Indiana, United States
  • Investigator site US0010042 Iowa City, Iowa, United States
View all 83 locations
View Trial Details

Related conditions